Navigation Links
Pinpointing a culprit molecule in Alzheimer's disease

One puzzle in Alzheimer's disease (AD) research is why mice engineered to have the abnormal protein underlying the disease in humans show little pathology of the disease. Specifically, such mice are genetically altered to overproduce mutant human amyloid precursor protein (APP). It is this protein that, when clipped by enzymes, produces the amyloid beta (Ab) peptide that clusters into the amyloid plaque that clogs the brain and kills brain cells.

The clipping of APP produces two types of amyloid beta peptide--one 40 amino acid units long (Ab40) and one 42 units long (Ab42). Circumstantial evidence has suggested that Ab42 is the "stickier" of the two forms, and underlies the pathology of the disease.

Now, researchers led by Eileen McGowan and Todd Golde of the Mayo Clinic College of Medicine report in the July 21, 2005, issue of Neuron definitive proof that Ab42 is, indeed, the culprit molecule. In their experiments, they created transgenic mice that overproduced either Ab40 or Ab42 in the absence of overproduction of APP. Thus, they could precisely study the role of each of these molecules in AD pathology.

Their studies of the mice revealed that the Ab40 mice showed little amyloid disease pathology in the animals' brains, while the Ab42 mice showed extensive accumulation of amyloid plaque and resulting neural damage. What's more, when the researchers crossed the Ab42 mice with those producing mutant APP, they saw a massive increase in amyloid deposition that was more than the additive effect of the two mutations.

The researchers pointed out that test tube studies have shown that Ab42 aggregates more readily. "Thus, the simplest explanation for the complete lack of pathology in the [Ab40] mice would be the relative inability of Ab40 to initiate nucleation events capable of promoting amyloid deposition," they wrote.

One question the new transgenic mice might help address, wrote the researchers, is whether Ab peptide does damage i nside brain cells or outside--"intracellularly." Transgenic mice produced by other researchers have not settled this question, because the peptide was not efficiently secreted by the cells in those mice. However, wrote McGowan and colleagues, "The [Ab] mice that we have developed are clearly distinct from these other "minigene" models in that they efficiently secrete Ab. To date we have little evidence for the accumulation of intracellular Ab in these mice; thus, they provide an excellent tool to study the effects of secreted Ab independently of APP transgenes."

McGowan et al.: "Aß42 is Essential for Parenchymal and Vascular Amyloid Deposition in Mice" Publishing in Neuron, Vol. 47, July 21, 2005, pages 191?99. DOI 10.1016/j.neuron.2005.06.030. www.neuron.org


'"/>

Source:Cell Press


Related biology news :

1. Pinpointing the cause of a neurodegenerative disorder
2. Chemists create Superbowl molecule; May lead to better health
3. Key molecule in plant photo-protection identified
4. Inflammatory molecules released by pollen trigger allergies
5. Researchers discover molecule that causes secondary stroke
6. Yale researchers identify molecule for detecting parasitic infection in humans
7. Scientists identify molecule that regulates well-known tumor suppressor
8. Medical molecules designed to respond to visible light that can penetrate tissue
9. Researchers find promising cancer-fighting power of synthetic cell-signaling molecule
10. Chemists synthesize molecule that helps body battle cancers, malaria
11. DNA constraints control structure of attached macromolecules
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider ... introduction of Onitor Track, an innovative biometric data-driven program ... showcasing this month at the 2017 Consumer Electronics Show ... In the U.S., the World Health Organization ... than two-thirds of adults who are overweight or obese. ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... MD (PRWEB) , ... January ... ... the market’s rapid adoption of Limfinity® Cloud, RURO has enhanced the platform ... cross-continent user groups, federated login, rapid data searching, and more. In addition ...
(Date:1/11/2017)... -- Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic ... will be attending the 47th Annual World Economic Forum ... 17-20, 2017. This will be Dr. Mehling,s fifth year ... this year,s forum is Responsive and Responsible Leadership; over ... for fostering greater social inclusion and human development. One-third ...
(Date:1/11/2017)... ... 11, 2017 , ... For many fledging startups, good advice ... young businesses face. With the second installment of Quorum’s newest signature program, Entrepreneur ... Founder and Principal of interactive design agency, P’unk Ave. , For the ...
(Date:1/11/2017)... , Jan. 11, 2017 AnaptysBio, Inc., ... candidates focused on unmet medical needs in inflammation, ... as chief financial officer.  Mr. Piscitelli will ... as well as overseeing the company,s accounting and ... pleased to welcome Dominic to the senior management ...
Breaking Biology Technology: